Log In
Print this Print this

Inhaled L-CsA

  Manage Alerts
Collapse Summary General Information
Company Pari GmbH
DescriptionInhaled liposomal cyclosporine A, an immunosuppressant agent delivered via the company's eFlow Nebulizer System
Molecular Target Cyclophilin
Mechanism of ActionCalcineurin inhibitor
Therapeutic ModalityMacrocycle
Latest Stage of DevelopmentPhase I
Standard IndicationGraft rejection
Indication DetailsMinimize the risk of graft rejection in lung transplants; Prevent bronchiolitis obliterans in lung transplant recipients; Prevent graft rejection
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today